Journal Mobile Options
Table of Contents
Vol. 42, No. 4, 2009
Issue release date: June 2009
Psychopathology 2009;42:257–263
(DOI:10.1159/000224149)

Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality Disorder

Tadić A. · Wagner S. · Hoch J. · Başkaya Ö. · von Cube R. · Skaletz C. · Lieb K. · Dahmen N.
Departments of aPsychiatry and bPsychology, University of Mainz, Mainz, cClinic of Psychiatry, Riedstadt, and dClinic of Psychiatry, Katzenelnbogen, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background/Aims: Differences in the clinical presentation of men and women with borderline personality disorder (BPD) are of potential interest for investigations into the neurobiology, genetics, natural history, and treatment response of BPD. The purpose of this study was to investigate gender differences in axis I and axis II comorbidity and in diagnostic criteria in BPD patients. Methods: 110 women and 49 men with BPD were assessed with the computer-based version of the Munich-Composite International Diagnostic Interview and the Structured Clinical Interview for DSM-IV Personality Disorders. Gender differences were investigated for the following outcomes: (a) lifetime, 12-month and 4-week prevalence of axis I disorders; (b) axis II disorders, and (c) DSM-IV BPD diagnostic criteria. Results: With regard to lifetime prevalence of axis I disorders, men more often displayed a substance use disorder, in particular alcohol dependency (65 vs. 43%); on the other hand, women more frequently had an affective (94 vs. 82%), anxiety (92 vs. 80%) or eating disorder (35 vs. 18%), in particular anorexia nervosa (21 vs. 4%). Regarding the 12-month prevalence, we found significantly more women suffering from anorexia nervosa (13 vs. 0%). Considering the 4-week prevalence, there were no significant gender differences. With regard to axis II disorders, men had a higher frequency of antisocial personality disorder (57 vs. 26%). Regarding the BPD diagnostic criteria, men more often displayed ‘intensive anger’ (74 vs. 49%), whereas women more frequently showed ‘affective instability’ (94 vs. 82%). Conclusion: In this German study, we could replicate and extend the findings from previous US studies, where men and women with BPD showed important differences in their pattern of psychiatric comorbidity. The implications for clinicians and researchers are discussed.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lenzenweger MF, Lane MC, Loranger AW, Kessler RC: DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;62:553–564.
  2. Torgersen S, Kringlen E, Cramer V: The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58:590–596.
  3. American Psychiatric Association Practice Guidelines: Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001;158(10 suppl):1–52.
  4. Black DW, Blum N, Letuchy E, Carney Doebbeling C, Forman-Hoffman VL, Doebbeling BN: Borderline personality disorder and traits in veterans: psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity. CNS Spectr 2006;11:680–689.
  5. Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, Grilo CM, Shea MT, Zanarini MC, Morey LC, Sanislow CA, Oldham JM: Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry 2002;159:276–283.
  6. Fyer MR, Frances AJ, Sullivan T, Hurt SW, Clarkin J: Comorbidity of borderline personality disorder. Arch Gen Psychiatry 1988;45:348–352.
  7. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V: Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998;155:1733–1739.
  8. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V: Axis II comorbidity of borderline personality disorder. Compr Psychiatry 1998;39:296–302.
  9. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M: Borderline personality disorder. Lancet 2004;364:453–461.
  10. Swartz MS, Blazer D, Goerge L, Winfiled I: Estimating the prevalence of borderline personality disorder in the community. J Personal Disord 1990;4:257–272.
  11. Coid J, Yang M, Tyrer P, Roberts A, Ullrich S: Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry 2006;188:423–431.
  12. Akhtar S, Byrne JP, Doghramji K: The demographic profile of borderline personality disorder. J Clin Psychiatry 1986;47:196–198.
  13. Widiger TA, Trull T: Borderline and narcissistic personality disorders; in Sutker P, Adams H (eds): Comprehensive Textbook of Psychopathology, ed 2. New York, Plenum, 1993, pp 371–394.
  14. Skodol AE, Bender DS: Why are women diagnosed borderline more than men? Psychiatr Q 2003;74:349–360.
  15. Johnson DM, Shea MT, Yen S, Battle CL, Zlotnick C, Sanislow CA, Grilo CM, Skodol AE, Bender DS, McGlashan TH, Gunderson JG, Zanarini MC: Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorder Study. Compr Psychiatry 2003;44:284–292.
  16. Zlotnick C, Rothschild L, Zimmerman M: The role of gender in the clinical presentation of patients with borderline personality disorder. J Personal Disord 2002;16:277–282.
  17. Morrow J, Nolen-Hoeksema S: Effects of responses to depression on the remediation of depressive affect. J Pers Soc Psychol 1990;58:519–527.
  18. McCormick B, Blum N, Hansel R, Franklin JA, St John D, Pfohl B, Allen J, Black DW: Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder. Compr Psychiatry 2007;48:406–412.
  19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
  20. Wittchen HU, Zaudig M, Fydrich T: SKID-I/-II: Strukturiertes klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1996.
  21. Wittchen HU, Lachner G, Wunderlich U, Pfister H: Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998;33:568–578.
  22. Fydrich T, Renneberg B, Schmitz B, Wittchen HU: Strukturiertes klinisches Interview für DSM-IV, Achse II (SKID-II; Persönlichkeitsstörungen). Göttingen, Hogrefe, 1997.
  23. Krueger RF: The structure of common mental disorders. Arch Gen Psychiatry 1999;56:921–926.
  24. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8–19.
  25. Wittchen HU, Jacobi F: Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357–376.
  26. Jacobi F, Wittchen HU, Holting C, Höfler M, Pfister H, Müller N, Lieb R: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34:597–611.
  27. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR: Axis I comorbidity in patients with Borderline Personality Disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry 2004;161:2108–2114.
  28. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J, Group for the Study of Resistant Depression: Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 2007;68:1062–1070.
  29. Lenzenweger MF: Epidemiology of personality disorders. Psychiatr Clin North Am 2008;31:395–403.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50